Literature DB >> 10875236

Activation of signal transducer and activator of transcription-3 during proliferative phases of 3T3-L1 adipogenesis.

J Deng1, K Hua, S S Lesser, J B Harp.   

Abstract

Signal transducer and activator of transcription-3 (STAT3) is abundantly expressed in preadipocytes and adipocytes, but little is known about its activation status or functional role during adipogenesis. In this report we investigate STAT3 activation in 3T3-L1 preadipocytes before and after differentiation into adipocytes. STAT3 was highly tyrosine phosphorylated and bound to DNA in proliferating preadipocytes, but not in growth-arrested preadipocytes or adipocytes. In growth-arrested confluent preadipocytes, induction of differentiation with methylisobutylxanthine, dexamethasone, and high dose insulin led to a delayed, but prolonged (3-day), increase in STAT3 tyrosine phosphorylation. This increase in STAT3 phosphorylation coincided temporally with postconfluent preadipocyte mitotic clonal expansion. Insulin and methylisobutylxanthine alone, but not dexamethasone, induced STAT3 tyrosine phosphorylation in postconfluent cells. Diminution of endogenous STAT3 expression by antisense morpholino oligonucleotides significantly decreased preconfluent preadipocyte proliferation. Collectively, these findings suggest a regulatory role for STAT3 during the proliferative phases of adipogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875236     DOI: 10.1210/endo.141.7.7551

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.

Authors:  Olivier Le Bacquer; Emmanuel Petroulakis; Sabina Paglialunga; Francis Poulin; Denis Richard; Katherine Cianflone; Nahum Sonenberg
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 2.  Adipogenesis.

Authors:  Kelesha Sarjeant; Jacqueline M Stephens
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

Review 3.  Emerging roles of JAK-STAT signaling pathways in adipocytes.

Authors:  Allison J Richard; Jacqueline M Stephens
Journal:  Trends Endocrinol Metab       Date:  2011-05-10       Impact factor: 12.015

4.  B cell translocation gene 2 (Btg2) is regulated by Stat3 signaling and inhibits adipocyte differentiation.

Authors:  Suji Kim; Joung-Woo Hong; Kye Won Park
Journal:  Mol Cell Biochem       Date:  2016-01-06       Impact factor: 3.396

Review 5.  Mitochondrial STAT3 and reactive oxygen species: A fulcrum of adipogenesis?

Authors:  Adam H Kramer; Rose Kadye; Pascalene S Houseman; Earl Prinsloo
Journal:  JAKSTAT       Date:  2015-09-11

6.  Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity.

Authors:  Erin R Cernkovich; Jianbei Deng; Michael C Bond; Terry P Combs; Joyce B Harp
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

7.  Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling.

Authors:  Stephen A Whelan; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2008-06-02       Impact factor: 5.157

Review 8.  The role of JAK-STAT signaling in adipose tissue function.

Authors:  Allison J Richard; Jacqueline M Stephens
Journal:  Biochim Biophys Acta       Date:  2013-06-02

9.  STAT3 suppresses Wnt/β-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis.

Authors:  Marc T Cantwell; Jared S Farrar; Joseph C Lownik; Jeremy A Meier; Moonjung Hyun; Vidisha Raje; Michael R Waters; Francesco S Celi; Daniel H Conrad; Thurl E Harris; Andrew C Larner
Journal:  Cytokine       Date:  2018-06-19       Impact factor: 3.861

10.  Control of adipogenic commitment by a STAT3-VSTM2A axis.

Authors:  Manal Al Dow; Maruhen Amir Datsch Silveira; Audrée Poliquin; Laura Tribouillard; Éric Fournier; Eva Trébaol; Blandine Secco; Romain Villot; Félix Tremblay; Steve Bilodeau; Mathieu Laplante
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-11-16       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.